Kimberly Chew will present, "Navigating Legal Challenges in Research: Best Practices Under the Federal Analogue Act," at the 4th Annual Psychedelic Therapeutics and Drug Development Conference on Thursday, May 23, 2024.
This session will provide researchers with a comprehensive understanding and practical approach to complying with the Federal Analogue Act. Attendees will gain insights into best practices for handling controlled substances and analogues, ensuring both scientific integrity and adherence to federal regulations. The goal of this session is to equip researchers with practical knowledge to conduct compliance-focused research, emphasizing legality and ethical practices. The speakers will clarify the process and requirements for obtaining necessary registrations for substance handling in research and development and provide actionable guidance on the management, storage, and disposal of controlled substances within research environments. Lastly, they will share a framework for training and supervising research personnel in the context of controlled substance regulations.
For more information, visit the event website.